Biotech Archives - Page 705 of 733

2 minute read

Cornerstone Pharmaceuticals Announces Successful Completion Of Phase 1b Clinical Trial For CPI-613 In Combination With Gemcitabine And Cisplatin In Patients With Biliary Tract Cancer

August 3, 8:12 AM

Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced the successful

RFL

2 minute read

Establishment Labs Announces Complete Enrollment In Motiva US IDE Study

By Benzinga Newsdesk

August 3, 8:06 AM

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has

ESTA

2 minute read

Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 2, 6:39 PM

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and…

AVTX

1 minute read

Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus

By Vandana Singh

August 2, 1:50 PM

Emergent BioSolutions Inc’s (NYSE: EBS) Q2 sales fell 39% Y/Y to $242.7 million, missing the consensus of $270.94 million. Revenues from…

AZN

1 minute read

Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition

By Vandana Singh

August 2, 1:46 PM

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) announced that over 35 physicians have written 50+ prescriptions for Imcivree (setmelanotide) for Bardet-Biedl syndrome…

RYTM

1 minute read

Vaxxinity’s Vaccine Candidate Shows Durable Cholesterol Lowering Activity In Animal Models

By Vandana Singh

August 2, 1:43 PM

Vaxxinity Inc (NASDAQ:VAXX) announced data demonstrating durable lowering of low-density lipoprotein (LDL) cholesterol in non-human primates. The company also selected VXX-401…

VAXX

1 minute read

AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement

By Vandana Singh

August 2, 6:32 AM

Sosei Group Corporation and AbbVie Inc (NYSE:ABBV) announced a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules…

ABBV

4 minute read

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 1, 6:41 PM

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…

AERI

1 minute read

Aerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study

By Ragothaman Srinivasan

August 1, 5:03 PM

Aerie Pharmaceuticals (NASDAQ: AERI) has initiated patient dosing in the Phase 3 registrational COMET-3 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).

AERI

1 minute read

‘Novel Approach For Retinal Disease Needs’ Stock Belite Bio Has 70% Potential Upside According To This Analyst

By Vandana Singh

August 1, 2:36 PM

HC Wainwright initiated coverage on Belite Bio Inc (NASDAQ:BLTE) with a Buy rating and price target of $58 per ADS. Belite Bio…

BLTE